AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
11 268 GBX
0.16%
Market Closed
Updated:
Apr 24, 2024
AstraZeneca PLC
Revenue
Last
Value
3-Years CAGR
5-Years CAGR
|
AstraZeneca PLC
Revenue Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Revenue
$45.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Revenue
£30.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Revenue
$1.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Revenue
$2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Revenue
£761.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
See Also
What is AstraZeneca PLC's Revenue?
Revenue
45.8B
USD
45.8B
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Revenue amounts to 45.8B USD.
What is AstraZeneca PLC's Revenue growth rate?
Revenue CAGR 10Y
6%
6%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for AstraZeneca PLC have been 20% over the past three years , 16% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
